Cardiology: Interventions: Genetic Testing For Clopidogrel “Resistance”; Research from SCAI, HRS, EuroPCR

The latest issue of Cardiology: Interventions highlights key trials from SCAI, HRS and EuroPCR and provides a closer look at the potential for axillary artery access for large bore catheter interventions. Editor-in-Chief Peter C. Block, MD, FACC, also reviews what current evidence tells us about genetic testing for clopidogrel “resistance” and what may be effective strategies for prescribing P2Y12 inhibitors. Also get key points to remember about Takotsubo Syndrome from a new international consensus document and don’t miss a conversation with Roxana Mehran, MD, FACC, on diversity and inclusion in interventional cardiology.  Get the full issue at